Oxidative stress is associated with decreased heart rate variability in patients with chronic kidney disease

Fadaee, Shannon B., Beetham, Kassia S., Howden, Erin J., Stanton, Tony, Isbel, Nicole M. and Coombes, Jeff S. (2016) Oxidative stress is associated with decreased heart rate variability in patients with chronic kidney disease. Redox Report: Communications in Free Radical Research, . doi:10.1080/13510002.2016.1173326


Author Fadaee, Shannon B.
Beetham, Kassia S.
Howden, Erin J.
Stanton, Tony
Isbel, Nicole M.
Coombes, Jeff S.
Title Oxidative stress is associated with decreased heart rate variability in patients with chronic kidney disease
Journal name Redox Report: Communications in Free Radical Research   Check publisher's open access policy
ISSN 1743-2928
1351-0002
Publication date 2016-04-19
Year available 2016
Sub-type Article (original research)
DOI 10.1080/13510002.2016.1173326
Open Access Status Not Open Access
Total pages 8
Place of publication Abingdon, Oxfordshire, United Kingdom
Publisher Taylor & Francis
Collection year 2017
Language eng
Formatted abstract
Objectives: Elevated oxidative stress and reduced heart rate variability (HRV) is prevalent in patients with chronic kidney disease (CKD) and is associated with increased morbidity and mortality. Previous studies have identified a positive association between elevated oxidative stress and autonomic dysfunction, however this relationship has not yet been investigated in the CKD population.

Methods: Plasma was collected from 78 patients with stage 3–4 CKD (estimated glomerular filtration rate 25–60 ml/min/1.73 m2) for the assessment of oxidative stress, including plasma total F2-isoprostanes, glutathione peroxidase activity and total antioxidant capacity. Time and frequency HRV parameters were measured from a three lead electrocardiogram.

Results: Participants with elevated F2-isoprostanes had reduced HRV compared to patients with normal levels of F2-isoprostanes. A number of HRV parameters were found to be inversely correlated with F2-isoprostanes in all CKD patients, including SDNN (r = −0.337; P < 0.01), VLF (r = −0.281, P = 0.01), LF (r = −0.315, P < 0.01) and total power (r = −0.288, P = 0.01). Multiple linear regression found F2-isoprostanes to be an independent predictor of SDNN (r2 = 0.287, β = −0.272, P = 0.01).

Discussion: Oxidative stress is significantly and independently associated with HRV in patients with CKD. Identifying oxidative stress in the pathogenesis of autonomic dysfunction may help target therapeutic strategies.
Keyword Autonomic dysfunction
Chronic kidney disease
Heart rate variability
Oxidative stress
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status UQ

 
Versions
Version Filter Type
Citation counts: Scopus Citation Count Cited 0 times in Scopus Article
Google Scholar Search Google Scholar
Created: Wed, 01 Jun 2016, 14:08:18 EST by Sandrine Ducrot on behalf of School of Human Movement and Nutrition Sciences